Sildenafil Citrate of in Vitro Fertilization After Multiple IVF Failures Attributed to Poor Endometrial Development
NCT ID: NCT03044561
Last Updated: 2017-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
80 participants
INTERVENTIONAL
2017-01-31
2017-08-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Vaginal Sildenafil Citrate on Endometrial Preparation and Outcome in Frozen Thawed Embryo Transfer Cycles
NCT03854175
Sildenafil and Outcome of IVF/ICSI Cycles
NCT03192709
Effect Sildenafil and Estradiiol Valerate on Endometrial Thickness in Infertile Women
NCT03301233
Endometrial Effects of Sildenafil in Frozen-Thawed Cycles in Women With Thin Endometrium
NCT04283435
Effect of Sildenafil Citrate on Mid Luteal Phase Uterine Artery Blood Flow in Patients With Recurrent Pregnancy Loss
NCT04718233
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sildenafil citrate
Sildenafil Citrate
25 mg orally, 4 times per day for 21 days
placebo
matching placebo
orally, 4 times per day for 21 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sildenafil Citrate
25 mg orally, 4 times per day for 21 days
matching placebo
orally, 4 times per day for 21 days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* (2) Body mass index (BMI):20-29.
* (3) women have experienced two or more implantation failure attributed to inadequate endometrial development.
Exclusion Criteria
* (2) Any contraindication to sildenafil citrate or any of the components of its formulation including:
* Concurrent use of organic nitrites and nitrates.
* Severe hepatic impairment.
* Severe renal impairment.
* Hypotension.
* Recent stroke or heart attack.
20 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amr El-Sayed
principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ahmed khairy, professor
Role: STUDY_DIRECTOR
Ain Shams University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain shams university
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
ahmed khairy, professor
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
amr elsayed
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
amr el-sayed 2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.